Variant report
Variant | nsv522908 |
---|---|
Chromosome Location | chr5:100309166-100340406 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:149222329..149224621-chr5:100319591..100321091,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000206737 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2216614 | chr5:100309166-100309167 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs540815140 | chr5:100309184-100309185 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532724137 | chr5:100318628-100318629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111471676 | chr5:100318637-100318638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183200562 | chr5:100318638-100318639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541048699 | chr5:100318691-100318692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3940391 | chr5:100318715-100318716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2400308 | chr5:100318718-100318719 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs187771335 | chr5:100318724-100318725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3940390 | chr5:100318730-100318731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs3940389 | chr5:100318784-100318785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs35979964 | chr5:100318790-100318791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200893159 | chr5:100318794-100318795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371075031 | chr5:100318802-100318803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530028414 | chr5:100318805-100318806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533561820 | chr5:100318811-100318812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551782474 | chr5:100318888-100318889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117673739 | chr5:100318900-100318901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556419254 | chr5:100318901-100318902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530395876 | chr5:100318905-100318906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116356944 | chr5:100318907-100318908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535604671 | chr5:100318977-100318978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142116456 | chr5:100318997-100318998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540710668 | chr5:100319023-100319024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558717187 | chr5:100319028-100319029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577162683 | chr5:100319092-100319093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531048966 | chr5:100319112-100319113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191924418 | chr5:100319130-100319131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369361186 | chr5:100319176-100319177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150870863 | chr5:100319177-100319178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541989905 | chr5:100319199-100319200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571083266 | chr5:100319210-100319211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182936857 | chr5:100319231-100319232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186903655 | chr5:100319244-100319245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192644972 | chr5:100319263-100319264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570399161 | chr5:100319296-100319297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531290529 | chr5:100319307-100319308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549817428 | chr5:100319309-100319310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528751207 | chr5:100319329-100319330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535669993 | chr5:100319363-100319364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111368782 | chr5:100319367-100319368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565866669 | chr5:100319385-100319386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139367922 | chr5:100319404-100319405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs56250756 | chr5:100319409-100319410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577175783 | chr5:100319412-100319413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544558151 | chr5:100319466-100319467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532232933 | chr5:100319472-100319473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556598603 | chr5:100319495-100319496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574818791 | chr5:100319496-100319497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146643064 | chr5:100319524-100319525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:100307400-100309200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:100318600-100319400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr5:100318600-100320000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr5:100319400-100322800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr5:100319600-100319800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr5:100322800-100326200 | Active TSS | HUES6 Cell Line | embryonic stem cell |
7 | chr5:100335400-100336400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr5:100339400-100340400 | Enhancers | Dnd41 | blood |